Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSanofi Share News (SAN.PA)

Share Price Information for Sanofi (SAN.PA)

Euronext Paris
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 90.79
Bid: 93.35
Ask: 93.36
Change: -0.20 (-0.22%)
Spread: 0.01 (0.011%)
Open: 92.56
High: 92.71
Low: 90.28
Prev. Close: 90.87
SAN.PA Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

British equities slip on higher yields, financials drag

Tue, 02nd Jan 2024 17:05

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Marks and Spencer rises on ratings upgrade

*

AstraZeneca up as RSV infant shots approved in China

*

UK factory revival prospects suffer setback in Dec

Jan 2 (Reuters) - London stocks started the year on a sombre note, weighed down by losses in the financial sector and as UK government bond yields climbed to two-weeks high.

The blue-chip FTSE 100 fell 0.2% on Tuesday, after hitting an over seven-month high earlier in the session, while the mid-cap FTSE 250 index was down 0.9%.

Yields on the benchmark 10-year government bond rose over 15 basis points to 3.695%, touching a more than two-week high, tracking moves in U.S. Treasuries as investors moved away from higher risk assets.

The investment banking and brokerage services index led the losses with a 2.2% fall, closely followed by a 1.9% decline in life insurance stocks.

Meanwhile, the FTSE 100 completed its 40th trading year.

"The headline index has made almost no progress since the start of the century, and in the last decade the Footsie has been totally eclipsed by the U.S. stock market," said Laith Khalaf, head of investment analysis at AJ Bell.

Top performer pharma and biotech shares jumped 1.7%, supported by a 1.8% rise in AstraZeneca after the drugmaker's respiratory syncytial virus (RSV) immunisation for infants developed with Sanofi got approval in China.

Oil and gas shares added 0.4% as crude prices moved higher on the prospect of Middle Eastern supply disruptions after a naval clash in the Red Sea.

"Fundamentally, while supply continues to outstrip demand, the escalating hostilities in the Red Sea are raising concerns and providing support," said David Morrison, senior market analyst at Trade Nation.

Among individual movers, Marks and Spencer advanced 1.3% after Exane BNP Paribas raised the retailer's stock rating to "outperform" from "neutral".

Britain's manufacturing sector suffered a setback in its recovery efforts as output and employment fell more sharply in December than in the previous month, according to a survey.

Another set of data showed prices charged by British store chains rose at the slowest pace in a year and a half in December, an industry group said. (Reporting by Khushi Singh, Shubham Batra and Shashwat Chauhan in Bengaluru; Editing by Shinjini Ganguli and Mark Potter)

More News
25 Apr 2024 06:30

Sanofi Q1 profit slips on generic competition, forex effects

April 25 (Reuters) - Sanofi's said on Thursday first-quarter operating income declined 14.7% as unfavourable currency effects and cheap competition to multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent.

Read more
12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugely popular Wegovy, are linked to suicidal thoughts, it said on Friday, ending a nine-month probe.

Read more
4 Apr 2024 00:03

Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

NEW YORK, April 3 (Reuters) - Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday.

Read more
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
10 Jan 2024 06:00

Drugs group Sanofi makes Olympic jump in rebrand bid

LONDON, Jan 10 (Reuters) - Sanofi is hoping that by sponsoring the Olympic Games it can attract new talent, reward existing staff and shake off the French drugmaker's conservative image.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
21 Dec 2023 15:07

IPO hopes rise for new year after Fed's early holiday gift

LONDON, Dec 21 (Reuters) - Bankers advising companies on stock market listings are hopeful that the new year will bring a recovery in initial public offerings after the U.S. Federal Reserve signalled it may start reversing the fastest escalation in interest rates in decades.

Read more
21 Dec 2023 12:44

IPO hopes rise for new year after Fed's early holiday gift

LONDON, Dec 21 (Reuters) - Bankers advising companies on stock market listings are hopeful that the new year will bring a recovery in initial public offerings after the U.S. Federal Reserve signalled it may start reversing the fastest escalation in interest rates in decades.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
21 Aug 2023 22:37

US FDA approves Pfizer's maternal RSV vaccine to protect infants

Aug 21 (Reuters) - The U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies.

Read more
28 Jul 2023 17:31

European shares slip overall but German blue-chips hit record high

STOXX 600 dips 0.2% but posts weekly gains

*

Read more
10 Jul 2023 19:33

EU investigates Ozempic, weight-loss drug Saxenda after suicidal thoughts reported

July 10 (Reuters) - The European Medicines Agency (EMA) is investigating Novo Nordisk's diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland's health regulator flagged three cases of patients thinking about suicide or self-harm.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.